Susan M. Jackson

FDA investigator · also recorded as Reve Rlen Susan Jackson

Appears on 13 documents from 2012 to 2023, most often at sites in Massachusetts. Most often cites production record review (21 CFR 211.192).

13
Documents on file
5.2
Observations per 483
2012
First seen
2023
Most recent

What they cite most

From 64 observations

Activity by year

2012: 1, 2014: 2, 2017: 1, 2018: 1, 2019: 2, 2020: 1, 2021: 3, 2022: 1, 2023: 1

Where

Massachusetts 2 · New York 2 · North Carolina 2 · Belgium 1 · California 1 · Florida 1

Is Susan M. Jackson coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

13 documents, newest first
FirmOpen
483 Dendreon Pharmaceuticals LLCAug 10, 2023 · Seal Beach, California
483 Grifols Therapeutics LLCMay 6, 2022 · Clayton, North Carolina
483 Endo USA, Inc.Oct 22, 2021 · Rochester, Michigan
EIR Pfizer Manufacturing Belgium NVJul 2, 2021 · Puurs, Belgium
483 Kedrion Biopharma Inc.Jun 25, 2021 · Melville, New York
483 Merck Sharp & Dohme LLCMar 4, 2020 · Elkton, Virginia
483 MassBiologicsNov 19, 2019 · Boston, Massachusetts

About this profile

What does Susan M. Jackson inspect?

Susan M. Jackson appears on 13 documents on file covering 12 sites, most often in Massachusetts.

What do they cite most often?

21 CFR 211.192 (production record review), followed by 21 CFR 211.100 and 21 CFR 211.113.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Susan M. Jackson is dated Aug 10, 2023.